215 related articles for article (PubMed ID: 7799065)
1. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
Lipp RW; Silly H; Ranner G; Dobnig H; Passath A; Leb G; Krejs GJ
J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin-receptor imaging in lymphoma.
Goldsmith SJ; Macapinlac HA; O'Brien JP
Semin Nucl Med; 1995 Jul; 25(3):262-71. PubMed ID: 7570045
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor-based imaging in malignant lymphomas.
O'Brien JP
J Nucl Med; 1995 Jan; 36(1):19-20. PubMed ID: 7799074
[No Abstract] [Full Text] [Related]
4. Visualization of non-Hodgkin's lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography.
Lipp RW; Schnedl WJ; Aglas F; Ranner G; Beham-Schmid C; Leb G; Sill H
Acta Med Austriaca; 1999; 26(3):105-8. PubMed ID: 10520379
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography.
Bares R; Galonska P; Dempke W; Handt S; Büll U; Osieka R
Horm Metab Res Suppl; 1993; 27():56-8. PubMed ID: 8330873
[TBL] [Abstract][Full Text] [Related]
6. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.
Reubi JC; Waser B; van Hagen M; Lamberts SW; Krenning EP; Gebbers JO; Laissue JA
Int J Cancer; 1992 Apr; 50(6):895-900. PubMed ID: 1348240
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor scintigraphy in the staging of lymphomas.
Ivancević V; Wörmann B; Nauck C; Sandrock D; Munz DL; Hiddemann W; Emrich D
Leuk Lymphoma; 1997 Jun; 26(1-2):107-14. PubMed ID: 9250794
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
Lugtenburg PJ; Löwenberg B; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Krenning EP
J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
Krenning EP; Bakker WH; Kooij PP; Breeman WA; Oei HY; de Jong M; Reubi JC; Visser TJ; Bruns C; Kwekkeboom DJ
J Nucl Med; 1992 May; 33(5):652-8. PubMed ID: 1349039
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor imaging.
Kwekkeboom DJ; Krenning EP
Semin Nucl Med; 2002 Apr; 32(2):84-91. PubMed ID: 11965603
[TBL] [Abstract][Full Text] [Related]
12. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
Baudin E; Lumbroso J; Schlumberger M; Leclere J; Giammarile F; Gardet P; Roche A; Travagli JP; Parmentier C
J Nucl Med; 1996 Jun; 37(6):912-6. PubMed ID: 8683310
[TBL] [Abstract][Full Text] [Related]
13. 111In-octreotide scintigraphy in oncology.
Krenning EP; Kwekkeboom DJ; Reubi JC; van Hagen PM; van Eijck CH; Oei HY; Lamberts SW
Digestion; 1993; 54 Suppl 1():84-7. PubMed ID: 8359573
[TBL] [Abstract][Full Text] [Related]
14. 111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
Li S; Kurtaran A; Li M; Traub-Weidinger T; Kienast O; Schima W; Angelberger P; Virgolini I; Raderer M; Dudczak R
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1087-95. PubMed ID: 12768334
[TBL] [Abstract][Full Text] [Related]
15. The relevance of somatostatin receptor expression in malignant lymphomas.
van den Anker-Lugtenburg PJ; Löwenberg B; Lamberts SW; Krenning EP
Metabolism; 1996 Aug; 45(8 Suppl 1):96-7. PubMed ID: 8769395
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor scintigraphy in cutaneous malignant lymphomas.
van den Anker-Lugtenburg PJ; Heule F; Vanhagen PM; van Joost T; Oei HY; Löwenberg B; Krenning EP
J Am Acad Dermatol; 1996 Jun; 34(6):985-93. PubMed ID: 8647992
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability.
Haldemann AR; Rösler H; Barth A; Waser B; Geiger L; Godoy N; Markwalder RV; Seiler RW; Sulzer M; Reubi JC
J Nucl Med; 1995 Mar; 36(3):403-10. PubMed ID: 7884502
[TBL] [Abstract][Full Text] [Related]
18. Indium-111 pentetreotide scintigraphy in malignant lymphomas.
Sarda L; Duet M; Zini JM; Berolatti B; Benelhadj S; Tobelem G; Mundler O
Eur J Nucl Med; 1995 Oct; 22(10):1105-9. PubMed ID: 8542892
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison.
de Kerviler E; Cadiot G; Lebtahi R; Faraggi M; Le Guludec D; Mignon M
Eur J Nucl Med; 1994 Nov; 21(11):1191-7. PubMed ID: 7859770
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.
Gibril F; Reynolds JC; Doppman JL; Chen CC; Venzon DJ; Termanini B; Weber HC; Stewart CA; Jensen RT
Ann Intern Med; 1996 Jul; 125(1):26-34. PubMed ID: 8644985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
